| Lauren Marciano Malo, AUD | |
|
148 W River St Ste 2a, Providence, RI 02904-2615 | |
| (401) 728-0140 | |
| Not Available |
| Full Name | Lauren Marciano Malo |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 2 Years |
| Location | 148 W River St Ste 2a, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255060133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 277 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ri Ear Nose And Throat Physicians Inc | 8921109448 | 9 |
News Archive
Researchers have uncovered a potential biological factor that may contribute to disparities in prostate cancer incidence and mortality between African-American and non-Hispanic white men in the United States, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
The differentiation of human epidermis is controlled and stabilized by a long noncoding RNA termed terminal differentiation-induced noncoding RNA acting through a post-transcriptional mechanism, the results of an innovative US study indicate.
For the first time, the research group of Prof. Claudia Waskow at the Carl Gustav Carus Faculty of Medicine at Dresden Technical University is now describing a new mechanism in which the length of the G1 phase of the cell cycle has a dramatic impact on the fitness of human blood stem cells.
These results from studies in both experimental and theoretical physics may help to improve antibacterial surfaces. The research work was recently published in the journal 'Nanoscale'.
› Verified 9 days ago
| Provider Name | Ri Ear Nose & Throat Physicians Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093861049 PECOS PAC ID: 8921109448 Enrollment ID: O20070726000805 |
News Archive
Researchers have uncovered a potential biological factor that may contribute to disparities in prostate cancer incidence and mortality between African-American and non-Hispanic white men in the United States, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
The differentiation of human epidermis is controlled and stabilized by a long noncoding RNA termed terminal differentiation-induced noncoding RNA acting through a post-transcriptional mechanism, the results of an innovative US study indicate.
For the first time, the research group of Prof. Claudia Waskow at the Carl Gustav Carus Faculty of Medicine at Dresden Technical University is now describing a new mechanism in which the length of the G1 phase of the cell cycle has a dramatic impact on the fitness of human blood stem cells.
These results from studies in both experimental and theoretical physics may help to improve antibacterial surfaces. The research work was recently published in the journal 'Nanoscale'.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Marciano Malo, AUD 148 W River St Ste 2a, Providence, RI 02904-2615 Ph: (401) 728-0140 | Lauren Marciano Malo, AUD 148 W River St Ste 2a, Providence, RI 02904-2615 Ph: (401) 728-0140 |
News Archive
Researchers have uncovered a potential biological factor that may contribute to disparities in prostate cancer incidence and mortality between African-American and non-Hispanic white men in the United States, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
The differentiation of human epidermis is controlled and stabilized by a long noncoding RNA termed terminal differentiation-induced noncoding RNA acting through a post-transcriptional mechanism, the results of an innovative US study indicate.
For the first time, the research group of Prof. Claudia Waskow at the Carl Gustav Carus Faculty of Medicine at Dresden Technical University is now describing a new mechanism in which the length of the G1 phase of the cell cycle has a dramatic impact on the fitness of human blood stem cells.
These results from studies in both experimental and theoretical physics may help to improve antibacterial surfaces. The research work was recently published in the journal 'Nanoscale'.
› Verified 9 days ago
Mr. Paul William Austin, M.ED., CCC-SLP-A Audiologist Medicare: Medicare Enrolled Practice Location: 115 Georgia Ave., Providence, RI 02905 Phone: 401-444-5485 Fax: 401-444-6212 | |
Dr. Stephany Faye Hanna, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 134 Thurbers Ave Ste 215, Providence, RI 02905 Phone: 401-453-7751 | |
Dr. Andrew Peter Mcgrath, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 134 Thurbers Ave Ste 215, Providence, RI 02905 Phone: 401-453-7751 Fax: 401-276-7813 | |
Dr. Brianna Robichaud, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 134 Thurbers Ave Ste 212, Providence, RI 02905 Phone: 401-453-7618 | |
Ms. Patricia Mary Sherman, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 115 Georgia Ave, Providence, RI 02905 Phone: 401-444-4052 Fax: 401-444-6212 | |
Winnie Chung, MD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1100 |